Xtant Medical Holdings, Inc. SEC filings XTNT
Xtant Medical Holdings, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Aug 1, 2011. Its latest annual report, Form ARS, was filed on Jun 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 11, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SD | Specialized disclosure (conflict minerals) | May 29, 2026 | — |
| SD | Specialized disclosure (conflict minerals) | May 30, 2025 | — |
| EFFECT | Filing | May 19, 2025 | — |
| CORRESP | Letter to the SEC | May 15, 2025 | — |
| UPLOAD | Letter from the SEC | May 15, 2025 | — |
| EFFECT | Filing | May 13, 2025 | — |
| EFFECT | Filing | May 13, 2025 | — |
| EFFECT | Filing | May 13, 2025 | — |
| EFFECT | Filing | May 13, 2025 | — |
| EFFECT | Filing | May 13, 2025 | — |
| EFFECT | Filing | May 13, 2025 | — |
| EFFECT | Filing | May 13, 2025 | — |
| EFFECT | Filing | May 13, 2025 | — |
| EFFECT | Filing | May 13, 2025 | — |
| EFFECT | Filing | Sep 11, 2024 | — |
| EFFECT | Filing | Sep 9, 2024 | — |
| CORRESP | Letter to the SEC | Sep 9, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 9, 2024 | — |
| D | Filing | Aug 12, 2024 | — |
| EFFECT | Filing | Apr 8, 2024 | — |
| CORRESP | Letter to the SEC | Apr 4, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 2, 2024 | — |
| EFFECT | Filing | Jul 13, 2023 | — |
| D | Filing | Jul 12, 2023 | — |
| CORRESP | Letter to the SEC | Jul 11, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 10, 2023 | — |
| EFFECT | Filing | Oct 20, 2022 | — |
| CORRESP | Letter to the SEC | Oct 18, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 17, 2022 | — |
| D | Filing | Aug 26, 2022 | — |
| 8-A12B/A | Filing | Mar 8, 2022 | — |
| EFFECT | Filing | May 18, 2021 | — |
| CORRESP | Letter to the SEC | May 14, 2021 | — |
| UPLOAD | Letter from the SEC | May 14, 2021 | — |
| EFFECT | Filing | Apr 14, 2021 | — |
| CORRESP | Letter to the SEC | Apr 12, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 9, 2021 | — |
| EFFECT | Filing | Mar 3, 2021 | — |
| D | Filing | Feb 26, 2021 | — |
| EFFECT | Filing | Dec 23, 2020 | — |
| CORRESP | Letter to the SEC | Dec 22, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 22, 2020 | — |
| DEL AM | Filing | Dec 22, 2020 | — |
| EFFECT | Filing | Nov 3, 2020 | — |
| CORRESP | Letter to the SEC | Oct 30, 2020 | — |
| D | Filing | Oct 5, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 15, 2020 | — |
| DEFR14A | Filing | Jun 26, 2018 | — |
| EFFECT | Filing | Jun 4, 2018 | — |
| CORRESP | Letter to the SEC | Jun 1, 2018 | — |
| CORRESP | Letter to the SEC | May 30, 2018 | — |
| UPLOAD | Letter from the SEC | May 23, 2018 | — |
| EFFECT | Filing | Apr 27, 2018 | — |
| CORRESP | Letter to the SEC | Apr 25, 2018 | — |
| CORRESP | Letter to the SEC | Apr 17, 2018 | — |
| UPLOAD | Letter from the SEC | Apr 13, 2018 | — |
| CORRESP | Letter to the SEC | Apr 9, 2018 | — |
| UPLOAD | Letter from the SEC | Feb 27, 2018 | — |
| NT 10-Q | Filing | Nov 9, 2017 | Sep 30, 2017 |
| EFFECT | Filing | Nov 21, 2016 | — |
| EFFECT | Filing | Oct 31, 2016 | — |
| CORRESP | Letter to the SEC | Oct 28, 2016 | — |
| CORRESP | Letter to the SEC | Oct 28, 2016 | — |
| UPLOAD | Letter from the SEC | Oct 27, 2016 | — |
| CORRESP | Letter to the SEC | Oct 17, 2016 | — |
| UPLOAD | Letter from the SEC | Oct 6, 2016 | — |
| CORRESP | Letter to the SEC | Sep 28, 2016 | — |
| UPLOAD | Letter from the SEC | Sep 21, 2016 | — |
| EFFECT | Filing | Jul 7, 2016 | — |
| CORRESP | Letter to the SEC | Jul 6, 2016 | — |
| CORRESP | Letter to the SEC | Jun 28, 2016 | — |
| UPLOAD | Letter from the SEC | Jun 27, 2016 | — |
| CORRESP | Letter to the SEC | Jun 17, 2016 | — |
| EFFECT | Filing | Jun 13, 2016 | — |
| CORRESP | Letter to the SEC | Jun 10, 2016 | — |
| CORRESP | Letter to the SEC | Jun 7, 2016 | — |
| CORRESP | Letter to the SEC | Jun 3, 2016 | — |
| UPLOAD | Letter from the SEC | May 26, 2016 | — |
| CORRESP | Letter to the SEC | May 2, 2016 | — |
| CORRESP | Letter to the SEC | May 2, 2016 | — |
| CORRESP | Letter to the SEC | Apr 29, 2016 | — |
| UPLOAD | Letter from the SEC | Jan 15, 2016 | — |
| CERTNYS | Auto-generated paper document | Oct 15, 2015 | — |
| 8-A12B | Filing | Oct 15, 2015 | — |
| EFFECT | Filing | Sep 8, 2015 | — |
| 25-NSE | Delisting notice | May 6, 2015 | — |
| EFFECT | Filing | Apr 27, 2015 | — |
| PRER14A | Filing | May 5, 2014 | — |
| EFFECT | Filing | Apr 8, 2014 | — |
| EFFECT | Filing | Jul 24, 2013 | — |
| EFFECT | Filing | Jul 15, 2013 | — |
| D | Filing | Jun 24, 2013 | — |
Showing 92 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- XTNT (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Belgrade, MT
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1453593
- Former names
- Bacterin International Holdings, Inc. (until Aug 3, 2015); K KITZ INC (until May 21, 2010)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.